NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 28, 2025 — Oragenics announces a 1-for-30 reverse stock split to boost share price and appeal to investors. CEO Janet Huffman aims to enhance the company's capital markets profile while advancing treatments for brain-related health conditions.
May 28, 2025 — New research reveals racial and ethnic disparities in sodium intake, emphasizing the need for customized advice. Understanding cultural differences in salt usage is crucial for reducing high blood pressure and cardiovascular disease risk.
May 28, 2025 — Unchained Leader program receives global recognition for positive impact on mental health. Founded by Mason Cain, the 90-day self-help program offers personalized treatment plans and a supportive community for lasting healing and freedom.
May 27, 2025 — Homewatch CareGivers of Houston Galleria ranked #1 in Houston for in-home senior care, offering compassionate, nurse-guided services. Learn why they're trusted.
May 27, 2025 — GeoVax Labs announces strong support for FDA's updated COVID-19 vaccine recommendations, highlighting the importance of tailored vaccine solutions for vulnerable populations. Learn how the multi-antigen vaccine, GEO-CM04S1, aims to provide comprehensive immune responses in high-risk individuals.
May 27, 2025 — Discover how a new swallowable pill is changing the game for gut health monitoring. Learn how advancements in tracking mucosal barrier integrity could revolutionize the diagnosis and treatment of gut-related conditions. Stay informed on the latest breakthroughs in healthcare technology.
May 27, 2025 — Discover the gold standard in aesthetic surgery at The Maercks Institute, where innovation and elegance meet for pain-free procedures and natural results. Dr. Rian Maercks' global perspective on beauty sets a new standard in patient care, providing a uniquely refined path to self-enhancement.
May 27, 2025 — Nutriband CEO Gareth Sheridan discusses the company's AVERSA(TM) platform in The BioMedWire Podcast, offering insights into transdermal drug delivery systems and pain management. Learn how Nutriband aims to improve safety and accessibility in the fentanyl patch market.
May 27, 2025 — Healthcare Triangle, Inc. (HCTI) unveils QuantumNexis, a subsidiary focused on AI-powered SaaS solutions for healthcare. With the acquisition of Niyama Healthcare and Ezovion Solutions, HCTI aims to address global healthcare demands and lead in Gen AI-powered technology.
May 27, 2025 — American Heart Association launches initiative to improve access to gene editing therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) in underserved populations. Learn how this program aims to enhance patient care and outcomes for a specific heart condition.
May 25, 2025 — Skin, Bones, Hearts & Private Parts is hosting a CME conference in Nashville, TN from August 25-28, 2025. Earn up to 26 CME credits and 7.50 APRN Pharmacology credits. Expert speakers to cover Dermatology, Diabetes, Orthopedics, Women's Health, Cardiology, and Emergency Medicine.
May 24, 2025 — CD BioSciences launches customizable aging mouse models for drug development, providing valuable tools for researchers in the aging research sector. With precision-driven customization and accelerated drug development timelines, CD BioSciences offers a strategic edge for pharmaceutical companies in aging-related drug discovery.
May 23, 2025 — Ethema Health Corporation releases annual report with revenue growth and new facility expansions in Florida and Kentucky. The update showcases the company's commitment to quality patient care and strategic growth initiatives in the behavioral healthcare sector.
May 23, 2025 — Beam Therapeutics announces presentation of BEAM-101 trial data at EHA Congress 2025, highlighting the therapy's potential to provide a durable treatment for sickle cell disease. The focus on precision genetic medicines through base editing could revolutionize treatment approaches for genetic disorders.
May 23, 2025 — Beam Therapeutics announces presentation of BEAM-101 trial data at EHA 2025 Congress, showcasing potential breakthrough treatment for sickle cell disease.
May 23, 2025 — Soligenix introduces SGX943, a novel therapy to combat antibiotic-resistant bacteria. Learn more about the innovative solution to the public health threat posed by antibiotic misuse.
May 23, 2025 — Intelligent Bio Solutions is on track for a 2025 U.S. launch of its non-invasive drug screening system with high accuracy in detecting opiates through fingerprint sweat. Learn more about the company's innovative technology and the potential impact on various industries.
May 23, 2025 — Creative Biolabs leads in CAR-T therapy development, offering end-to-end solutions for plasmids, CAR viral vectors, and CAR cells. With increasing market demand, the company is crucial in accelerating research projects and bringing new therapies to patients in need.
May 22, 2025 — Soligenix leads in innovative therapies for rare diseases like CTCL with its treatment HyBryte(TM) and vaccine development programs for diseases like COVID-19 and Ebola. Learn more about the company's groundbreaking work and potential impact on rare disease treatment.
May 22, 2025 — Calidi Biotherapeutics announces breakthrough in cancer treatment delivery with promising preclinical results for RTNova platform. The innovative technology targets cancer cells while minimizing harm to healthy tissues, potentially improving treatment outcomes and survival rates.